Johnson Chemical Pharmaceutical Works Co Ltd Cash Flow Conversion Efficiency
Johnson Chemical Pharmaceutical Works Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has a cash flow conversion efficiency ratio of 0.008x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$14.40 Million ≈ $453.84K USD) by net assets (NT$1.74 Billion ≈ $54.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4747 company net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Johnson Chemical Pharmaceutical Works Co Ltd (2009–2025)
Cash flow conversion efficiency of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2025. This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Johnson Chemical Pharmaceutical Works Co share price for real-time trading data and today's change.
Johnson Chemical Pharmaceutical Works Co Ltd Cash Flow Conversion Ratio Explained
Johnson Chemical Pharmaceutical Works Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their cash flow conversion efficiency. Review Johnson Chemical Pharmaceutical Works Co free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Roo Hsing Co Ltd
TW:4414
|
0.060x |
|
Elite Express Holding Inc. Class A Common Stock
NASDAQ:ETS
|
-0.167x |
|
Jayjun Co Ltd
KO:025620
|
-0.031x |
|
Cube Entertainment Inc
KQ:182360
|
-0.108x |
|
Tailyn Technologies
TWO:5353
|
0.003x |
|
3U Holding AG
XETRA:UUU
|
-0.009x |
|
Africa Energy Corp
V:AFE
|
-0.016x |
|
Sparebank 68 Grader Nord
OL:SB68
|
N/A |
Annual Cash Flow Conversion Efficiency for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2025)
The table below shows the annual cash flow conversion efficiency of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2025. Also see 4747 total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.71 Billion ≈ $53.86 Million |
NT$71.71 Million ≈ $2.26 Million |
0.042x | +13.67% |
| 2024-12-31 | NT$1.70 Billion ≈ $53.68 Million |
NT$62.88 Million ≈ $1.98 Million |
0.037x | -54.95% |
| 2023-12-31 | NT$1.67 Billion ≈ $52.68 Million |
NT$136.95 Million ≈ $4.31 Million |
0.082x | -20.39% |
| 2022-12-31 | NT$871.66 Million ≈ $27.46 Million |
NT$89.69 Million ≈ $2.83 Million |
0.103x | +66.72% |
| 2021-12-31 | NT$848.24 Million ≈ $26.72 Million |
NT$52.35 Million ≈ $1.65 Million |
0.062x | -26.21% |
| 2020-12-31 | NT$858.20 Million ≈ $27.04 Million |
NT$71.77 Million ≈ $2.26 Million |
0.084x | -0.84% |
| 2019-12-31 | NT$847.97 Million ≈ $26.72 Million |
NT$71.52 Million ≈ $2.25 Million |
0.084x | +3.52% |
| 2018-12-31 | NT$836.53 Million ≈ $26.36 Million |
NT$68.15 Million ≈ $2.15 Million |
0.081x | +70.61% |
| 2017-12-31 | NT$835.43 Million ≈ $26.32 Million |
NT$39.89 Million ≈ $1.26 Million |
0.048x | -41.76% |
| 2016-12-31 | NT$832.41 Million ≈ $26.23 Million |
NT$68.25 Million ≈ $2.15 Million |
0.082x | +60.49% |
| 2015-12-31 | NT$821.60 Million ≈ $25.88 Million |
NT$41.97 Million ≈ $1.32 Million |
0.051x | -60.87% |
| 2014-12-31 | NT$635.01 Million ≈ $20.01 Million |
NT$82.91 Million ≈ $2.61 Million |
0.131x | -3.19% |
| 2013-12-31 | NT$583.53 Million ≈ $18.38 Million |
NT$78.70 Million ≈ $2.48 Million |
0.135x | +80.40% |
| 2012-12-31 | NT$386.30 Million ≈ $12.17 Million |
NT$28.88 Million ≈ $909.94K |
0.075x | -47.75% |
| 2011-12-31 | NT$353.39 Million ≈ $11.13 Million |
NT$50.57 Million ≈ $1.59 Million |
0.143x | +66.91% |
| 2010-12-31 | NT$324.45 Million ≈ $10.22 Million |
NT$27.81 Million ≈ $876.26K |
0.086x | -7.16% |
| 2009-12-31 | NT$311.47 Million ≈ $9.81 Million |
NT$28.76 Million ≈ $906.10K |
0.092x | -- |
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more